3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Classical hematology
1
Conditions
Thrombocytopenia
1
Hematologic Neoplasms
1
Interventions
Cyclophosphamide
58
Busulfan
47
fludarabine phosphate
45
Cyclosporine
34
Mycophenolic Acid
31
Whole-Body Irradiation
29
Peripheral Blood Stem Cell Transplantation
29
fludarabine
27
Antilymphocyte Serum
27
Tacrolimus
26
Methotrexate
25
Melphalan
25
Filgrastim
20
Radiotherapy
19
Darbepoetin alfa
19
Cytarabine
19
Cord Blood Stem Cell Transplantation
18
Epoetin Alfa
17
Granulocyte Colony-Stimulating Factor
14
Methylprednisolone
13
thymoglobulin
10
Thiotepa
9
Etoposide
9
Alemtuzumab
9
eltrombopag
8
Stem Cell Transplantation
8
olaparib
7
sargramostim
6
hetrombopag
6
Rituximab
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Aminocaproic Acid
×
Classical hematology
×
Clear all
NCT02074436
2022-07-19
PROBLEMA
Emory University
Phase 2
Terminated
29 enrolled
10 charts